SAB Biotherapeutics ( ($SABS) ) has provided an update. On December 29, 2025, SAB Biotherapeutics, Inc. entered into a new sales agreement with ...

In Distress? Why The Balance Sheet Says No Despite $59B Bitcoin Holdings, MSCI Reclassification Risk, And Distressed ...

Discover why Edgewise Therapeutics, Inc. is rated Buy amid strong trial data, unique HCM treatment, and major 2026 catalysts. Click for this EWTX update.

Share Market highlights - Find here all the highlights related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 29th December 2025.

In 2018, e-commerce sales only accounted for 1% of Sprouts' revenue. This year, they made up 16% of it, and grew by 21% ...

Since President Donald Trump's 'Liberation Day' tariffs pushed the U.S. bond market into revolt in April, his administration ...

Precision BioSciences offers high-risk, high-reward potential, trading below cash with key HBV and DMD data catalysts ...

Palantir stock is up 155% so far this year -- the third-best performance in the Nasdaq-100 -- and that follows gains of 167% ...

Major stock indexes ended little changed Friday after traders got the day off for Christmas. Meanwhile, gold and silver set ...

ORLANDO, FL / ACCESS Newswire / December 26, 2025 / RedChip Companies will air interviews with Processa Pharmaceuticals, Inc.

Trump Accounts launch in 2026 for children born 2025–2028. Each starts with a $1,000 federal deposit. Families can add up to ...

One week from today, we'll be ringing in a new year -- and investors are likely to be smiling from ear to ear. As of the ...